Your browser doesn't support javascript.
loading
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
de Vries, Rory D; Altenburg, Arwen F; Nieuwkoop, Nella J; de Bruin, Erwin; van Trierum, Stella E; Pronk, Mark R; Lamers, Mart M; Richard, Mathilde; Nieuwenhuijse, David F; Koopmans, Marion P G; Kreijtz, Joost H C M; Fouchier, Ron A M; Osterhaus, Albert D M E; Sutter, Gerd; Rimmelzwaan, Guus F.
Afiliação
  • de Vries RD; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Altenburg AF; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Nieuwkoop NJ; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • de Bruin E; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Trierum SE; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Pronk MR; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Lamers MM; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Richard M; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Nieuwenhuijse DF; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Koopmans MPG; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Kreijtz JHCM; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Fouchier RAM; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Osterhaus ADME; Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Sutter G; Institute for Infectious Diseases and Zoonoses, Ludwig Maximilian University of Munich, Munich.
  • Rimmelzwaan GF; German Center for Infection Research, Hannover, Germany.
J Infect Dis ; 218(4): 614-623, 2018 07 13.
Article em En | MEDLINE | ID: mdl-29912453
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Linfócitos T / Glicoproteínas de Hemaglutininação de Vírus da Influenza / Influenza Humana / Virus da Influenza A Subtipo H5N1 / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Linfócitos T / Glicoproteínas de Hemaglutininação de Vírus da Influenza / Influenza Humana / Virus da Influenza A Subtipo H5N1 / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article